NHS platform announced to accelerate personalised cancer vaccine clinical trials The CVLP platform will speed up access to BioNTech and Genentech’s mRNA personalised cancer vaccines
Elicio’s vaccine shows promise as potential cancer treatment in phase 1 trial Results showed robust responses in patients with pancreatic and colorectal cancer